Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 6987240, 8 pages
https://doi.org/10.1155/2017/6987240
Research Article

Posttransplant Anemia as a Prognostic Factor of Mortality in Kidney-Transplant Recipients

1Fresenius Medical Care-Dialysis Services Slovakia, Kosice, Slovakia
2Graduate School Kosice Institute for Society and Health, Faculty of Medicine, Safarik University, Kosice, Slovakia
3Department of Health Psychology, Faculty of Medicine, Safarik University, Kosice, Slovakia
4Transplantation Department, Faculty of Medicine and University Hospital, Safarik University, Kosice, Slovakia
5St. Lukas Geriatric Centre, Kosice, Slovakia
6Department of Community & Occupational Health, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands

Correspondence should be addressed to Maria Majernikova; moc.liamg@nrejamam

Received 19 May 2016; Revised 29 August 2016; Accepted 26 February 2017; Published 19 March 2017

Academic Editor: Houry Puzantian

Copyright © 2017 Maria Majernikova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity, vol. 6, World Health Organization, Geneva, Switzerland, 2011.
  2. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, “KDIGO Clinical Practice Guideline for the care of kidney transplant recipients,” American Journal of Transplantation, vol. 9, supplement 3, pp. S1–S157, 2009. View at Google Scholar
  3. A. Mikhail, R. Shrivastava, and D. Richardson, Clinical Practice Guidelines Anaemia of CKD UK Renal Association, Final Version, 5th edition, 2009–2012, http://www.renal.org/docs/default-source/guidelines-resources/old-guidelines/anaemia-in-ckd-5th-editionef0fa231181561659443ff000014d4d8.pdf?sfvrsn=2.
  4. F. Locatelli, A. Covic, K.-U. Eckardt, A. Wiecek, and R. Vanholder, “Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP),” Nephrology Dialysis Transplantation, vol. 24, no. 2, pp. 348–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Abecassis, S. T. Bartlett, A. J. Collins et al., “Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) conference,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 2, pp. 471–480, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. “KDIGO clinical practice guideline for anemia in chronic kidney disease,” Kidney International Supplements, vol. 2, no. 4, pp. 331–335, 2012.
  7. A. Kainz, J. Wilflingseder, R. Függer, R. Kramar, and R. Oberbauer, “Hemoglobin variability after renal transplantation is associated with mortality,” Transplant International, vol. 25, no. 3, pp. 323–327, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Spiegel and G. M. Chertow, “Lost without directions: lessons from the anemia debate and the drive study,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 1009–1010, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. J. Augustine, T. C. Knauss, J. A. Schulak, K. A. Bodziak, C. Siegel, and D. E. Hricik, “Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients,” American Journal of Transplantation, vol. 4, no. 12, pp. 2001–2006, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Kreis, J.-M. Cisterne, W. Land et al., “Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients,” Transplantation, vol. 69, no. 7, pp. 1252–1260, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Z. Molnar, I. Mucsi, I. C. Macdougall et al., “Prevalence and management of anaemia in renal transplant recipients: data from ten European centres,” Nephron—Clinical Practice, vol. 117, no. 2, pp. c127–c134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Ponticelli, J. Morales, D. Abramowicz, K. Baboolal, and Y. Vanrenterghem, “Prevalence and management of anemia in renal transplant recipients: a European survey,” American Journal of Transplantation, vol. 3, no. 7, pp. 835–845, 2003. View at Google Scholar
  13. H. Jones, M. Talwar, J. M. Nogueira et al., “Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis,” Transplantation, vol. 93, no. 9, pp. 923–928, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Ott, M. Busch, T. Steiner, and G. Wolf, “Anemia after renal transplantation: an underestimated problem,” Transplantation Proceedings, vol. 40, no. 10, pp. 3481–3484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Mehrotra, “ESAs in transplant anemia: one size does not “fit all”,” Journal of the American Society of Nephrology, vol. 23, no. 2, pp. 192–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. Wolfe, V. B. Ashby, E. L. Milford et al., “Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant,” New England Journal of Medicine, vol. 341, no. 23, pp. 1725–1730, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. A. S. Levey and L. A. Stevens, “Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: More accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions,” American Journal of Kidney Diseases, vol. 55, no. 4, pp. 622–627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Sis, M. Mengel, M. Haas et al., “Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups,” American Journal of Transplantation, vol. 10, no. 3, pp. 464–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. The Criteria Committee of the New York Heart Association, Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, Little, Brown & Co, Boston, Mass, USA, 9th edition, 1994.
  20. A. Djamali, M. Samaniego, J. Torrealba, J. Pirsch, and B. L. Muth, “Increase in proteinuria >200 mg/g after late rejection is associated with poor graft survival,” Nephrology Dialysis Transplantation, vol. 25, no. 4, pp. 1300–1306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Nemati, V. Pourfarziani, A. M. Jafari et al., “Prediction of inpatient survival and graft loss in rehospitalized kidney recipients,” Transplantation Proceedings, vol. 39, no. 4, pp. 974–977, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Amaral, W. Hwang, B. Fivush, A. Neu, D. Frankenfield, and S. Furth, “Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis,” Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2878–2885, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Viklický, L. Janouek, and P. Baláž, Kidney Transplantation in Clinical Practice, Grada, Prague, Czech Republic, 2008.
  24. E. V. Lawler, D. R. Gagnon, J. Fink et al., “Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration,” Nephrology Dialysis Transplantation, vol. 25, no. 7, pp. 2237–2244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Iseki and K. Kohagura, “Anemia as a risk factor for chronic kidney disease,” Kidney International, vol. 72, no. 107, pp. S4–S9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Goldsmith, “2009: A requiem for rHuEPOs—but should we nail down the coffin in 2010?” Clinical Journal of the American Society of Nephrology, vol. 5, no. 5, pp. 929–935, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Kestenbaum, “Reevaluating erythropoiesis-stimulating agents,” New England Journal of Medicine, vol. 362, no. 18, pp. 1742–1744, 2010. View at Publisher · View at Google Scholar · View at Scopus